HP1-gamma holds a constitutive, sub-threshold foothold on the KMT2A exon-11 CTCF anchor in undamaged cells - the CTCF-primed model's missing resting state - and the reason nobody has seen it is that it sits below the reproducibility filter every public peak set applies
also called the sub-IDR HP1-gamma foothold · is the KMT2A anchor pre-licensed
One model of how the KMT2A gene breaks says a repair-licensing protein is only recruited after damage. A faint but reproducible signal for that protein sits on the exact spot in undamaged cells, which would mean the licence is partly pre-loaded rather than built from scratch - but the signal is faint enough that it might be nothing.
The same thing, for a scientist
**The model this tests.** `mechanism-ctcf-primes-repressive-chromatin-for-brca1-bard1-at-a-break` and `hyp-the-writer-reaches-the-kmt2a-anchor-only-through-ctcf-and-only-after-the-break` hold that CTCF recruits HP1-gamma, KAP1/TRIM28, SUV39H1, SETDB1 and KDM5A to a double-strand break, licensing BRCA1/BARD1 - and that in the resting state the *KMT2A* anchor carries no such address. Cycle 63 tested the resting state in ENCODE and reported nothing, which was taken as consistent with the model. **The hypothesis.** The resting state is **not** empty. HP1-gamma occupies the exon-11 CTCF anchor constitutively at a level that is real but below the IDR threshold, and BRCA1 does the same at a lower level. The break-induced step is then an **amplification of an existing foothold** rather than a recruitment from zero. **What generated it, and its weakness in the same sentence** [E1]. Three of 180 archived tracks call a peak on the element, two of them reproducibly in both biological replicates of ENCODE experiments, at global IDR 0.227 (CBX3, K562) and 0.0588 (BRCA1, HeLa-S3), with summits within 9 bp of the CTCF summit. **And the class-matched null says this is ordinary**: 30.2% of K562 CTCF anchors carry a CBX3 peak in the same track. So the observation is compatible with a specific foothold and equally compatible with HP1-gamma coating CTCF anchors generally - which would make the *KMT2A* anchor's occupancy true, uninteresting, and not evidence for this hypothesis at all. **Why it is worth stating rather than discarding.** The two readings make **different predictions that are cheap to separate**, and the discriminator is not the KMT2A anchor's absolute signal but its rank within its class and the behaviour of the six non-anchor intervals beside it. BRCA1 is the more informative protein here precisely because its class base rate is low (10.3% of HeLa CTCF anchors), so a BRCA1 foothold at this anchor is a much stronger observation than a CBX3 one. **And what it would change if true.** The CTCF arm and the menin arm are proposed in `hyp-the-menin-arm-and-the-ctcf-arm-license-consecutive-steps-of-one-resection-reaction` to license consecutive steps of one reaction. A constitutive HP1-gamma foothold would mean the *KMT2A* breakpoint cluster is **pre-licensed** for resection before any break occurs, which is a different account of why this locus breaks recurrently in utero than a purely damage-triggered cascade - and it would make the chromatin state at this anchor a standing property of the cell rather than a response.
| statement | In undamaged human cells, HP1-gamma (CBX3) occupies the KMT2A exon-11 CTCF anchor (GRCh38 chr11:118,488,614-118,488,760) constitutively at a level that is real but below the IDR 0.05 reproducibility threshold, and BRCA1 does so at a lower level; the damage-induced step described in the CTCF-primed model is therefore an amplification of an existing foothold rather than recruitment from zero. |
|---|---|
| origin | data-pattern |
| prior probability | 0.2 |
| prior reasoning | A called peak in 3 of 180 tracks with summits within 9 bp of the CTCF summit, reproducible in both replicates of two ENCODE experiments, is more than nothing. Against it: the class base rate for CBX3 at CTCF anchors is 30-67%, Q35's independent signal-level class-matched read put the element at 0.34-1.25x, and no track is in a KMT2A-rearranged or haematopoietic-progenitor cell. 0.2 is set below even odds deliberately, and the low-class-base-rate BRCA1 observation is what keeps it off the floor. |
| what it would change if true | The KMT2A breakpoint cluster would be pre-licensed for resection in the undamaged cell rather than licensed on demand, which bears on why this locus breaks recurrently in utero and makes the anchor's chromatin state a standing property rather than a response. It would also make the resting-state negatives in this graph - Q35's and this beat's - statements about assay sensitivity rather than about biology. |
| what it does NOT claim | It does not claim the anchor is special among CTCF anchors for CBX3; the class base rate of 30-67% says it probably is not. It does not claim any of this happens in a KMT2A-rearranged cell, where no CBX3 or BRCA1 occupancy data exists in any archive. And it does not claim a functional consequence of the foothold, which nothing here tests. |
predictions
[ "At signal level, the exon-11 anchor ranks above the 75th percentile of same-cell-type CTCF anchors for BRCA1 in most interpretable tracks, while the six non-anchor KMT2A intervals stay below the 50th.", "The effect is CTCF-dependent: in an acute CTCF-degron line (auxin-inducible, as in ChIP-Atlas SRX11361143/SRX11361144), CBX3 signal at the element falls by more than 2-fold within the degradation window while CBX3 signal averaged over the same cell's other CTCF anchors falls by a similar factor - i.e. the element behaves like its class, not uniquely.", "In a haematopoietic cell, a CUT&RUN for CBX3 - which has a far better signal-to-noise floor than crosslinked ChIP and therefore does not need the IDR rescue - calls a peak at the element without any threshold manipulation.", "Under damage, the signal at the element rises rather than appearing: a Cas9 break inside chr11:118,482,422-118,489,887 produces a CBX3 increase over the undamaged baseline at the element of at least 2-fold by 15 minutes, rather than a rise from a zero baseline." ]
experiments
[ "exp-idr-free-signal-level-reread-of-the-kmt2a-anchor-across-every-archived-cbx3-and-brca1-track" ]
analyses
[ "ana-q37-the-kmt2a-exon-11-anchor-carries-a-cbx3-and-a-brca1-peak-that-idr-removes", "ana-q37-the-resection-layer-outside-encode-a-three-archive-census-with-a-per-protein-absence-class" ]
falsifiers
[ "CLASS-MATCHED RANK. In a signal-level read of the 45 archived CBX3 tracks, the exon-11 anchor (GRCh38 chr11:118,488,614-118,488,760) sits between the 25th and 75th percentile of 2,000 width- and TSS-distance-matched CTCF anchors of the SAME cell type in the majority of tracks passing the dynamic-range gate. That is 'an ordinary CTCF anchor' and it kills the hypothesis as stated, leaving only the trivially true claim that CBX3 is where CBX3 usually is. Scoreable on public data with no wet work.", "BRCA1, THE DISCRIMINATING PROTEIN. BRCA1 occupies only 10.3% of HeLa-S3 CTCF anchors, so its class base rate is low enough to be informative. If the exon-11 anchor's class-matched percentile for BRCA1 is below the 50th in at least 20 of the 31 archived BRCA1 tracks, the foothold claim fails for the protein it most needed to hold for, because a CBX3-only result is indistinguishable from the class base rate.", "HAEMATOPOIETIC CUT&RUN. A CBX3 CUT&RUN in an undamaged KMT2A-rearranged B-lineage line (SEM or RS4;11, n >= 2 biological replicates, spike-in normalised) calls NO peak at chr11:118,488,159-118,489,206 at q < 0.01 while calling peaks at >= 20% of that cell's CTCF anchors. A sub-IDR crosslinked-ChIP signal that a higher-signal-to-noise assay cannot see in the disease cell type is a threshold artefact, and the hypothesis should be withdrawn.", "THE BASELINE UNDER DAMAGE. At a Cas9 break inside chr11:118,482,422-118,489,887 in a haematopoietic cell, CBX3 ChIP or CUT&RUN signal at the exon-11 anchor at 15 minutes exceeds the undamaged baseline by more than 5-fold. A rise that large from a baseline this beat calls a 'foothold' is recruitment from effectively nothing, and the amplification framing - which is the part of this hypothesis that differs from the existing CTCF-primed model - is wrong even though the occupancy claim may survive.", "THE INSTRUMENT ITSELF. If the same IDR-free re-read applied to 20 randomly chosen CTCF anchors in the same tracks recovers sub-threshold peaks at a comparable rate to the KMT2A anchor - specifically, if more than 30% of randomly chosen anchors show a pre-IDR peak that the thresholded file discards - then the observation that generated this hypothesis is a generic property of opening the pre-filter file and carries no information about KMT2A." ]
- If the anchor really is pre-licensed for resection, then an agent that removes the H3K9 axis to prevent KMT2A rearrangement is removing a standing repair licence rather than blocking an induced one, and the toxicity window is continuous rather than confined to the period of damage - a materially worse safety profile than `risk-an-h3k9-axis-inhibitor-given-with-a-top2-poison-removes-a-repair-licence` currently assumes.
- The hypothesis is also a way to keep a negative alive by lowering a threshold, and it was generated by doing exactly that. Falsifier five exists specifically to catch that: if opening the pre-filter file recovers discarded peaks at more than 30% of randomly chosen CTCF anchors, the whole observation is an artefact of the method that produced it.
- Is a constitutive foothold distinguishable from a low-level damage response in an asynchronous cancer line? K562, HeLa and HCT116 all carry endogenous double-strand breaks at any moment, so a population-average 'resting state' track already contains a fraction of damaged cells, and nothing in this design separates the two.
- Would the same sub-IDR analysis find a foothold at the AFF1, MLLT3 or MLLT1 breakpoint regions? If the foothold is a property of recurrent translocation partners rather than of KMT2A, that is a much larger claim and the coordinates are all in this graph already.
- Does the exon-11 anchor differ from other CTCF anchors in any measured property that would predict a foothold - loop strength, cohesin residency, replication timing? Q111 built a CTCF-anchor ranking for this locus and it has not been joined to this question.
- E1moderate confidence 3 of 5: One strong study, or several smaller consistent ones.dataset
The generating observation is a peak on the exon-11 CTCF element in three of 180 archived tracks, present in both biological replicates of two ENCODE experiments in their own pre-IDR files at global IDR 0.227 (CBX3, K562, ENCSR000BRT) and 0.0588 (BRCA1, HeLa-S3, ENCSR000EDB), with summits at 118,488,695 and 118,488,703 against a CTCF summit at 118,488,695.
ana-q37-the-kmt2a-exon-11-anchor-carries-a-cbx3-and-a-brca1-peak-that-idr-removes · Q37-archive-sweep · this graph 2026What this evidence cannot show
Three of 180 is a low hit rate and the three are among the deepest tracks in the sweep, so sensitivity and signal are confounded. An IDR of 0.227 is a legitimate rejection. None of the three cells is haematopoietic progenitor or KMT2A-rearranged: K562 is CML blast crisis, HeLa is cervical carcinoma, HCT116 is colorectal. This is a hypothesis-generating observation and is labelled speculative for that reason.
Evidence that argues against this (1)
- 30.2% of 44,722 K562 CTCF anchors carry a called CBX3 peak in the same track, and 66.9% of HCT116 anchors do. On that base rate a CBX3 peak at any given CTCF anchor is the expected case, and the KMT2A observation supports the hypothesis only through BRCA1, whose base rate is 10.3%. Q37-archive-sweep 2026
- E2strong confidence 4 of 5: Replicated in peer-reviewed work by more than one group.paper
The model this hypothesis modifies is established in a non-haematopoietic system: in U2OS and HEK-293T, CTCF recruits HP1-gamma, KAP1, SUV39H1, SETDB1 and KDM5A to double-strand breaks, enabling rapid and transient BRCA1/BARD1 accumulation and downstream resection, with HP1-gamma described as rapidly and transiently recruited.
CTCF primes repressive chromatin for rapid BRCA1/BARD1 recruitment to drive homologous recombination repair of DNA double-strand breaks. · Hwang SY, Choi D, Choi MJ, Jo HR, Jeong JH, Kang MA, Lee JS · Nucleic Acids Research 2026What this evidence cannot show
U2OS and HEK-293T only - an osteosarcoma and an embryonic kidney line, neither haematopoietic, neither KMT2A-rearranged, and the whole cascade is assumed here to transfer to a B-lineage progenitor, which is the same partner-imported-evidence weakness this graph records across 66% of its load-bearing items. The paper describes recruitment TO A BREAK and says nothing about a resting-state baseline at any locus, so the 'amplification rather than recruitment' framing is this hypothesis's addition and not the paper's claim.
Evidence that argues against this (1)
- The paper's own description of HP1-gamma as 'rapidly and transiently recruited' argues against a standing constitutive foothold: a factor with a pre-loaded baseline is not usually described as recruited. This hypothesis is in tension with the founding paper's own language, and that tension is the honest reason its prior is set at 0.2. Hwang SY et al. 2026
its 'at least 20 of the 31 archived BRCA1 tracks' clause is the worked example of a raw count that is SOUND, because 31 is fixed by the archive rather than being an outcome - this is what refines the cycle-76 blanket rule into a conditional one
generated by the three sub-IDR peaks
the no-wet-work class-matched signal-level read that scores falsifiers one and two
modifies it: amplification of a standing foothold rather than recruitment from zero
HP1-gamma is the protein the foothold is claimed for
if the licence is constitutive rather than induced, the toxicity window is continuous rather than damage-confined